225 related articles for article (PubMed ID: 26775631)
1. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
Levenick JM; Gordon SR; Fadden LL; Levy LC; Rockacy MJ; Hyder SM; Lacy BE; Bensen SP; Parr DD; Gardner TB
Gastroenterology; 2016 Apr; 150(4):911-7; quiz e19. PubMed ID: 26775631
[TBL] [Abstract][Full Text] [Related]
2. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
3. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
[TBL] [Abstract][Full Text] [Related]
4. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
[TBL] [Abstract][Full Text] [Related]
5. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
Fogel EL; Lehman GA; Tarnasky P; Cote GA; Schmidt SE; Waljee AK; Higgins PDR; Watkins JL; Sherman S; Kwon RSY; Elta GH; Easler JJ; Pleskow DK; Scheiman JM; El Hajj II; Guda NM; Gromski MA; McHenry L; Arol S; Korsnes S; Suarez AL; Spitzer R; Miller M; Hofbauer M; Elmunzer BJ;
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):132-141. PubMed ID: 31780277
[TBL] [Abstract][Full Text] [Related]
6. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial.
Elmunzer BJ; Serrano J; Chak A; Edmundowicz SA; Papachristou GI; Scheiman JM; Singh VK; Varadarajulu S; Vargo JJ; Willingham FF; Baron TH; Coté GA; Romagnuolo J; Wood-Williams A; Depue EK; Spitzer RL; Spino C; Foster LD; Durkalski V;
Trials; 2016 Mar; 17(1):120. PubMed ID: 26941086
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis.
Elmunzer BJ; Scheiman JM; Lehman GA; Chak A; Mosler P; Higgins PD; Hayward RA; Romagnuolo J; Elta GH; Sherman S; Waljee AK; Repaka A; Atkinson MR; Cote GA; Kwon RS; McHenry L; Piraka CR; Wamsteker EJ; Watkins JL; Korsnes SJ; Schmidt SE; Turner SM; Nicholson S; Fogel EL;
N Engl J Med; 2012 Apr; 366(15):1414-22. PubMed ID: 22494121
[TBL] [Abstract][Full Text] [Related]
9. Rectal Indomethacin and Spraying of Duodenal Papilla With Epinephrine Increases Risk of Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography.
Luo H; Wang X; Zhang R; Liang S; Kang X; Zhang X; Lou Q; Xiong K; Yang J; Si L; Liu W; Liu Y; Zhou Y; Wang S; Yang M; Chen W; Han Y; Shang G; Yang X; He Y; Zou Q; Guo W; Dai Y; Zeng W; Zhu X; Gong R; Li X; Nie Z; Wang Q; Wang L; Pan Y; Guo X; Fan D
Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1597-1606.e5. PubMed ID: 30391434
[TBL] [Abstract][Full Text] [Related]
10. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
Wan J; Ren Y; Zhu Z; Xia L; Lu N
BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
[TBL] [Abstract][Full Text] [Related]
11. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
[TBL] [Abstract][Full Text] [Related]
12. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
[No Abstract] [Full Text] [Related]
14. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
15. A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction.
Siddiqui AA; Patel D; Kaplan J; Zabolotsky AH; Loren D; Kowalski T; Ghumman SS; Adler DG; Munigal S; Hayat U; Eloubeidi MA
Dig Dis Sci; 2015 Aug; 60(8):2509-15. PubMed ID: 25868629
[TBL] [Abstract][Full Text] [Related]
16. Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation: results from a randomized study with sequential biliary intubation.
Patai Á; Solymosi N; Patai ÁV
J Clin Gastroenterol; 2015; 49(5):429-37. PubMed ID: 25790233
[TBL] [Abstract][Full Text] [Related]
17. Rectally administered indomethacin to prevent post-ESWL-pancreatitis (RIPEP): study protocol for a randomized controlled trial.
Qian YY; Chen H; Tang XY; Jiang X; Qian W; Zou WB; Xin L; Li B; Qi YF; Hu LH; Zou DW; Jin ZD; Wang D; Du YQ; Wang LW; Liu F; Li ZS; Liao Z
Trials; 2017 Nov; 18(1):513. PubMed ID: 29096689
[TBL] [Abstract][Full Text] [Related]
18. Low-dose rectal diclofenac does not prevent post-ERCP pancreatitis in low- or high-risk patients.
Katoh T; Kawashima K; Fukuba N; Masuda S; Kobatake H; Masaki K; Araki Y; Kawano K; Nishi K; Takenaka M; Ishihara S; Kinoshita Y
J Gastroenterol Hepatol; 2020 Jul; 35(7):1247-1253. PubMed ID: 31788849
[TBL] [Abstract][Full Text] [Related]
19. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial.
Luo H; Zhao L; Leung J; Zhang R; Liu Z; Wang X; Wang B; Nie Z; Lei T; Li X; Zhou W; Zhang L; Wang Q; Li M; Zhou Y; Liu Q; Sun H; Wang Z; Liang S; Guo X; Tao Q; Wu K; Pan Y; Guo X; Fan D
Lancet; 2016 Jun; 387(10035):2293-2301. PubMed ID: 27133971
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Post-ERCP Pancreatitis in High-Risk Patients Receiving Post-procedure Rectal Indomethacin.
Kang X; Zheng L; Zeng W; Yang S; Sun H; Zhang R; Wang X; Wang B; Tao Q; Yao S; Chen J; Pan Y; Guo X
J Gastrointest Surg; 2018 Nov; 22(11):1903-1910. PubMed ID: 29980976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]